Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DOFETILIDE vs DONANEMAB-AZBT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DOFETILIDE vs DONANEMAB-AZBT: Safety Overview

Metric DOFETILIDE DONANEMAB-AZBT
Total FAERS Reports 5,063 1,018
Deaths Reported 428 18
Death Rate 8.5% 1.8%
Hospitalizations 1,446 117
Average Patient Age 71.8 yrs 74.6 yrs
% Female Patients 51.3% 58.6%
FDA Approval Date Apr 10, 2018 N/A
Manufacturer Accord Healthcare, Inc. N/A
Route ORAL N/A
Marketing Status Prescription Prescription